Cargando…
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Doxorubicin (DOX) is a commonly used antineoplastic agent for the treatment of various malignancies, and its use is associated with unpredictable cardiotoxicity. Susceptibility to DOX cardiotoxicity is largely patient dependent, suggesting genetic predisposition. We have previously found that indivi...
Autores principales: | Todorova, Valentina K., Makhoul, Issam, Dhakal, Ishwori, Wei, Jeanne, Stone, Annjanette, Carter, Weleetka, Owen, Aaron, Klimberg, V. Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841056/ https://www.ncbi.nlm.nih.gov/pubmed/28256194 http://dx.doi.org/10.3727/096504017X14876245096439 |
Ejemplares similares
-
Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
por: Todorova, Valentina K., et al.
Publicado: (2016) -
Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model
por: Todorova, Valentina K., et al.
Publicado: (2012) -
Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
por: Bauer, Michael A., et al.
Publicado: (2021) -
Correction: Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model
por: Todorova, Valentina K., et al.
Publicado: (2013) -
Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
por: Todorova, Valentina K., et al.
Publicado: (2020)